Cured hepatitis C patients at risk for reinfection — 4 insights

Hepatitis C patients who treated infections with direct-acting antiviral agents still face a reinfection risk, according to MedPage Today.

Here's what you should know:

1. Research by Philadelphia-based Perelman School of Medicine HIV/Viral Hepatitis Coinfection Scientific Working Group Co-Director Vincent Lo Re, MD, stated that cured patients, even those that are HCV antibody-positive, are at risk for reinfection.

2. Researchers haven't established set reinfection rates among patients treated with direct-acting antiviral agents because studies are still ongoing.

3. Early findings show patients engaging in high-risk behaviors, like those who inject drugs, face heightened reinfection risks.

4. Reinfected patients need to undergo the same evaluation process a first-time patient would to determine appropriate course of treatment.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Learning Opportunities

Featured Webinars

Featured Whitepapers

Featured Podcast